Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. In memoriam Horst Bickel.

Background: Most reports on phenylketonuria (PKU) screening focused solely on the result of the initial investigation of the neonatal screening sample. The aim of this study was to evaluate an enzymatic phenylalanine (Phe) determination in the whole context spanning from the initial investigation ov...

Full description

Saved in:
Bibliographic Details
Main Authors: Schulze, Andreas (Author) , Mayatepek, Ertan (Author) , Hoffmann, Georg F. (Author)
Format: Article (Journal)
Language:English
Published: 2002
In: Clinica chimica acta
Year: 2002, Volume: 317, Issue: 1, Pages: 27-37
ISSN:1873-3492
DOI:10.1016/S0009-8981(01)00736-7
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S0009-8981(01)00736-7
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0009898101007367
Get full text
Author Notes:Andreas Schulze, Ertan Mayatepek, Georg F. Hoffmann

MARC

LEADER 00000caa a2200000 c 4500
001 1797008145
003 DE-627
005 20230428010711.0
007 cr uuu---uuuuu
008 220330s2002 xx |||||o 00| ||eng c
024 7 |a 10.1016/S0009-8981(01)00736-7  |2 doi 
035 |a (DE-627)1797008145 
035 |a (DE-599)KXP1797008145 
035 |a (OCoLC)1341446234 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schulze, Andreas  |d 1951-  |e VerfasserIn  |0 (DE-588)112294138  |0 (DE-627)691143927  |0 (DE-576)289726999  |4 aut 
245 1 0 |a Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. In memoriam Horst Bickel.  |c Andreas Schulze, Ertan Mayatepek, Georg F. Hoffmann 
264 1 |c 2002 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 18 October 2001 
500 |a Gesehen am 30.03.2022 
520 |a Background: Most reports on phenylketonuria (PKU) screening focused solely on the result of the initial investigation of the neonatal screening sample. The aim of this study was to evaluate an enzymatic phenylalanine (Phe) determination in the whole context spanning from the initial investigation over the recall period, up to the confirmation or exclusion of the disease. Methods: Phe of dried blood spot specimens was analysed colorimetrically in a microtitre-plate assay based on the l-phenylalanine dehydrogenase reaction coupled with an intermediate electron acceptor system. This assay was evaluated for analytical variables and for neonatal PKU screening in a total number of 423,773 neonates during a 6-year period. Results: Method validation with respect to linearity, precision (within-run CVs 3.4-4.2%, between-run CVs 6.2-10.4%), and accuracy fulfilled all requirements for a screening method. Mean Phe (±SD) of 130,000 healthy neonates was 84 (±22) μmol/l with a cut-off point (mean+3 SD) of 150 μmol/l. From 423,773 neonates, hyperphenylalaninemia was confirmed in 155 cases and further differentiated into PKU (41 cases, 27%), BH4 deficiency (3, 2%), non-PKU HPA (67, 43%), transient neonatal HPA (28, 18%), and secondary HPA (16, 10%). The number of false-positives (recall-rate) was 0.23%, and no false-negatives were noted. Conclusions: Detailed studies over a period of 6 years including more than 400,000 neonates clearly show that the enzymatic assay is a reliable and sensitive method for neonatal screening of PKU. The proven prevalence of non-PKU HPA in the German population disclosed by the assay was twice as high as compared to the “Guthrie test” used previously. The growing use and application of tandem mass spectrometry in neonatal screening will not derogate the usefulness of the enzymatic assay in PKU screening in the foreseeable future. Careful analysis of our screening results and monitoring of all pathological samples resulted in an evidence-based flow chart for a rational PKU screening. 
650 4 |a Phenylalanine determination 
650 4 |a Phenylketonuria 
650 4 |a Screening 
700 1 |a Mayatepek, Ertan  |e VerfasserIn  |0 (DE-588)13349005X  |0 (DE-627)546777678  |0 (DE-576)299882454  |4 aut 
700 1 |a Hoffmann, Georg F.  |d 1957-  |e VerfasserIn  |0 (DE-588)115652868  |0 (DE-627)077386116  |0 (DE-576)261230042  |4 aut 
773 0 8 |i Enthalten in  |t Clinica chimica acta  |d Amsterdam [u.a.] : Elsevier Science, 1956  |g 317(2002), 1, Seite 27-37  |h Online-Ressource  |w (DE-627)306654423  |w (DE-600)1499920-1  |w (DE-576)094531242  |x 1873-3492  |7 nnas  |a Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. In memoriam Horst Bickel. 
773 1 8 |g volume:317  |g year:2002  |g number:1  |g pages:27-37  |g extent:11  |a Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. In memoriam Horst Bickel. 
856 4 0 |u https://doi.org/10.1016/S0009-8981(01)00736-7  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0009898101007367  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220330 
994 |a 2002 
998 |g 115652868  |a Hoffmann, Georg F.  |m 115652868:Hoffmann, Georg F.  |d 910000  |d 910500  |e 910000PH115652868  |e 910500PH115652868  |k 0/910000/  |k 1/910000/910500/  |p 3  |y j 
998 |g 13349005X  |a Mayatepek, Ertan  |m 13349005X:Mayatepek, Ertan  |d 910000  |d 910500  |e 910000PM13349005X  |e 910500PM13349005X  |k 0/910000/  |k 1/910000/910500/  |p 2 
998 |g 112294138  |a Schulze, Andreas  |m 112294138:Schulze, Andreas  |d 910000  |d 910500  |e 910000PS112294138  |e 910500PS112294138  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1797008145  |e 4106875101 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 04.02.20"],"pubHistory":["1.1956 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Clinica chimica acta","title":"Clinica chimica acta","subtitle":"international journal of clinical chemistry and applied molecular biology"}],"recId":"306654423","disp":"Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. In memoriam Horst Bickel.Clinica chimica acta","id":{"eki":["306654423"],"zdb":["1499920-1"],"issn":["1873-3492"]},"origin":[{"dateIssuedDisp":"1956-","dateIssuedKey":"1956","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]"}],"part":{"text":"317(2002), 1, Seite 27-37","extent":"11","volume":"317","pages":"27-37","issue":"1","year":"2002"}}],"note":["Available online 18 October 2001","Gesehen am 30.03.2022"],"origin":[{"dateIssuedKey":"2002","dateIssuedDisp":"2002"}],"id":{"eki":["1797008145"],"doi":["10.1016/S0009-8981(01)00736-7"]},"recId":"1797008145","name":{"displayForm":["Andreas Schulze, Ertan Mayatepek, Georg F. Hoffmann"]},"title":[{"title":"Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. In memoriam Horst Bickel.","title_sort":"Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria. In memoriam Horst Bickel."}],"person":[{"display":"Schulze, Andreas","family":"Schulze","role":"aut","given":"Andreas"},{"display":"Mayatepek, Ertan","family":"Mayatepek","given":"Ertan","role":"aut"},{"display":"Hoffmann, Georg F.","role":"aut","given":"Georg F.","family":"Hoffmann"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"11 S."}],"language":["eng"]} 
SRT |a SCHULZEANDEVALUATION2002